Novel combination between 8-cyclopropyl-3-[2-(3-fluorophenyl) ethyl]-7,8-dihydro-3H-[1,3]oxazino[6,5-g][1,2,3]benzotriazine-4,9-dione and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing same
Combination between 8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8-dihydro-3H-[l,3] oxazino[6,5-g][l,2,3]benzotriazine-4,9-dione of formula (I) or an addition salt thereof with a pharmaceutically acceptable acid or base, and an acetylcholinesterase inhibitor.